Anavex Life Sciences宣布口服布拉卡美辛认知恢复力结果接近正常老化水平,精准医学临床数据来自阿尔茨海默病IIb/III期试验
Anavex Life Sciences宣布口服布拉卡美辛认知恢复力结果接近正常老化水平,精准医学临床数据来自阿尔茨海默病IIb/III期试验
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.